Lonza receives Swissmedic approval for Biologics drug product filling line in Stein
New filling line approval supports delivery of integrated, end-to-end solutions across the entire biologics and bioconjugates value chain
New filling line approval supports delivery of integrated, end-to-end solutions across the entire biologics and bioconjugates value chain
Conventional plasmids as a pharmaceutical material are not only suboptimal in safety and function, but exceedingly costly to produce, prohibitively
Furthering?U.S.-based?pharmaceutical?capacity?to?produce?critical respiratory medicines?
Medico Remedies receives order worth US$ 1,781,000
Max and Luna personify HRV Pharma’s core values of trust, loyalty, and authentic partnership
Through this acquisition Merck has added Ohtuvayre (ensifentrine) to its growing cardio-pulmonary pipeline and portfolio
New offering to debut at the 32nd ESGCT Congress, October 7–10, 2025, in Seville, Spain
IMCD engaged with manufacturers, formulators, and brand leaders, offering valuable insights into evolving consumer trends
Lonza boosts TheraPEAK line with new Cytokines and AAV Medium for next-gen therapies
Subscribe To Our Newsletter & Stay Updated